Anika Therapeutics (ANIK) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free ANIK Stock Alerts $25.40 -0.10 (-0.39%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16, 2024 | finance.yahoo.comPendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc®May 13, 2024 | americanbankingnews.comBrokers Offer Predictions for Anika Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ANIK)May 12, 2024 | americanbankingnews.comAnika Therapeutics' (ANIK) Outperform Rating Reiterated at Barrington ResearchMay 10, 2024 | finance.yahoo.comAnika Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2024 | finanznachrichten.deAnika Therapeutics Inc.: Anika Announces CFO TransitionMay 9, 2024 | marketbeat.comBarrington Research Reaffirms Outperform Rating for Anika Therapeutics (NASDAQ:ANIK)Barrington Research reissued an "outperform" rating and set a $37.00 price target on shares of Anika Therapeutics in a research report on Thursday.May 9, 2024 | finance.yahoo.comAnika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 8, 2024 | marketwatch.comAnika Names Steve Griffin as New Finance ChiefMay 8, 2024 | globenewswire.comAnika Announces CFO TransitionMay 8, 2024 | globenewswire.comAnika Reports First Quarter 2024 Financial ResultsMay 8, 2024 | finance.yahoo.comObsidian Therapeutics Appoints Dana Alexander as Chief Technical OfficerMay 6, 2024 | uk.finance.yahoo.comOsteoarthritis Market Forecast Reveals Significant Growth and Upcoming Therapeutic Advancements by 2032May 3, 2024 | globenewswire.comAnika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 1, 2024 | stocknews.com3 Biotech Stocks Heating up for MayMay 1, 2024 | marketbeat.comAnika Therapeutics (ANIK) to Release Earnings on WednesdayAnika Therapeutics (NASDAQ:ANIK) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=586440)May 1, 2024 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest UpdateAnika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 811,100 shares, an increase of 5.3% from the March 31st total of 770,400 shares. Currently, 5.7% of the company's stock are short sold. Based on an average daily volume of 81,800 shares, the short-interest ratio is presently 9.9 days.April 26, 2024 | yahoo.comFDA approves Pfizer’s first gene therapy for rare inherited bleeding disorderApril 25, 2024 | finance.yahoo.comAnika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years agoApril 20, 2024 | marketbeat.comCapital Management Corp VA Purchases 271,309 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)Capital Management Corp VA increased its position in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 322.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 355,534 shares of the biotechnology company's stock afterApril 18, 2024 | finance.yahoo.comAnika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024April 18, 2024 | globenewswire.comAnika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024April 2, 2024 | globenewswire.comAnika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 28, 2024 | msn.comViking Therapeutics stock jumps more than 15% on promising weight loss pill dataMarch 18, 2024 | marketbeat.comAnika Therapeutics (NASDAQ:ANIK) Given New $37.00 Price Target at Barrington ResearchBarrington Research upped their target price on Anika Therapeutics from $29.00 to $37.00 and gave the stock an "outperform" rating in a research report on Thursday.March 18, 2024 | marketbeat.comAnika Therapeutics (NASDAQ:ANIK) Earns "Equal Weight" Rating from StephensStephens reaffirmed an "equal weight" rating and set a $22.00 price target on shares of Anika Therapeutics in a research report on Thursday.March 16, 2024 | finance.yahoo.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | markets.businessinsider.comAnika Therapeutics: Strong Q4 Performance and Upbeat FY2024 Outlook Justify Buy Rating and Raised Price TargetMarch 14, 2024 | marketbeat.comStockNews.com Upgrades Anika Therapeutics (NASDAQ:ANIK) to BuyStockNews.com raised Anika Therapeutics from a "hold" rating to a "buy" rating in a report on Thursday.March 14, 2024 | finanznachrichten.deAnika Therapeutics Inc.: Anika Reports Fourth Quarter and Year-End 2023 Financial ResultsMarch 14, 2024 | marketwatch.comAnika Therapeutics to Cut Workforce by 9% in Push for ProfitabilityMarch 13, 2024 | globenewswire.comAnika Reports Fourth Quarter and Year-End 2023 Financial ResultsMarch 12, 2024 | msn.comAnika Therapeutics Q4 2023 Earnings PreviewMarch 12, 2024 | seekingalpha.comADC Therapeutics Q4 Earnings PreviewMarch 12, 2024 | benzinga.comEarnings Outlook For Anika TherapeuticsMarch 11, 2024 | marketbeat.comGSA Capital Partners LLP Acquires New Shares in Anika Therapeutics, Inc. (NASDAQ:ANIK)GSA Capital Partners LLP acquired a new stake in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 51,638 shares of the biotechnology company's stock, valued at approxMarch 8, 2024 | globenewswire.comAnika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 8, 2024 | reuters.comEurope waits on ECB as BOJ lights up the yenMarch 7, 2024 | finance.yahoo.comFifth Annual MedExecWomen Conference in April to Discuss This Year’s Top Opportunities in MedtechMarch 7, 2024 | msn.comActivist investor Caligan discloses 9.7% stake in Anika, nominates two director candidatesMarch 7, 2024 | marketbeat.com50,652 Shares in Anika Therapeutics, Inc. (NASDAQ:ANIK) Acquired by Trexquant Investment LPTrexquant Investment LP acquired a new position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 50,652 shares ofMarch 5, 2024 | marketbeat.comShort Interest in Anika Therapeutics, Inc. (NASDAQ:ANIK) Increases By 8.4%Anika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) saw a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 572,300 shares, a growth of 8.4% from the January 31st total of 527,800 shares. Based on an average daily trading volume, of 82,400 shares, the short-interest ratio is currently 6.9 days. Currently, 4.0% of the company's stock are short sold.March 1, 2024 | finance.yahoo.comViscosupplementation Market to Reach US$ 7.81 Billion by 2030: A Comprehensive Analysis of Industry Trends, Growth Drivers, and Market ShareFebruary 27, 2024 | globenewswire.comAnika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024February 23, 2024 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by Acadian Asset Management LLCAcadian Asset Management LLC raised its position in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 184.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 336,058 shares of the biotechnology compaFebruary 21, 2024 | finance.yahoo.comAnika Therapeutics Inc (AKP.BE)February 15, 2024 | finance.yahoo.comStoke Therapeutics, Inc. (STOK) Stock Jumps 25.5%: Will It Continue to Soar?February 9, 2024 | marketbeat.comJump Financial LLC Purchases New Shares in Anika Therapeutics, Inc. (NASDAQ:ANIK)Jump Financial LLC purchased a new position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 34,989 shares of the biotechnology company's stock, valuedFebruary 6, 2024 | finance.yahoo.comPixelgen Technologies and Australian Biosearch Announce Distribution AgreementFebruary 6, 2024 | ca.finance.yahoo.comAnika Therapeutics, Inc. (ANIK)January 22, 2024 | finance.yahoo.comViscosupplementation Market Size Worth USD 10.51 Billion in 2032 | Emergen Research Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market. Click for his six specific AI stock in the crosshairs ANIK Media Mentions By Week ANIK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIK News Sentiment▼-0.400.42▲Average Medical News Sentiment ANIK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIK Articles This Week▼51▲ANIK Articles Average Week Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cerus News OraSure Technologies News Utah Medical Products News Atrion News Nevro News Pulmonx News Beauty Health News Pulse Biosciences News Tactile Systems Technology News Fractyl Health News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIK) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
